In a significant move toward the Indian pharmaceutical industry, Procter and Gamble (P&G) would invest over Rs 2,000 crore in Gujarat to have a state of the art manufacturing facility of psyllium husk based-Laxative drugs...
The Kingdom of Saudi Arabia (KSA) is contacting Indian pharmaceutical and medical device businesses for strategic partnerships and investment in its quickly growing healthcare sector, which is a significant step towards strengthening bilateral
Novo Nordisk is doubling its India operations as it has launched a major expansion at its Global Business Services (GBS) hub in Bengaluru. In July 2025, the company grew its workforce from 2,500 to over 4,500 employees to reflect its strategy...
Torrent Pharmaceuticals is preparing to launch semaglutide, both oral and injectable, once the patent for the drug expires in early 2026. This positions Torrent as one of the initial entries in the race for India's pharmaceutical players to get...
Akums Drugs & Pharmaceuticals Ltd., India’s largest contract manufacturing pharmaceutical company, is proud to announce that its Sterile Manufacturing Plant has received the prestigious Good Manufacturing Practice(GMP) Certificate from ANVISA...
India's drug and pharmaceutical exports have increased by 92%, from Rs 1,28,028 crore in FY2018-19 to Rs 2,45,962 crore in FY2024-25, thanks to a number of initiatives the Center is implementing to realize the vision of Aatmanirbhar Bharat
Discover how contract pharmaceutical manufacturers can tap into the booming weight-loss drug market. Explore CDMO strategies, regulatory trends, and GLP-1 production insights for 2025 and beyond.
In a move to gain traction in the consumer healthcare market, Torrent Pharmaceuticals has launched Shelcal Total, a complete nutrition supplement powder for adults. “India is facing a growing nutrition gap driven by lifestyle changes...
Through its clinical-stage biotech subsidiary Sathgen Therapeutics, Godavari Biorefineries Limited has received a patent for its innovative anti-cancer chemical, HYDROXY-1,4-NAPHTHALENEDIONE, from China's patent and trademark authority, the China
In a massive push to turn India pharma-independent, the central government has sanctioned 48 new projects under the PLI scheme to increase domestic production of essential drug ingredients called APIs and KSMs...
.jpg)
, CDSCO.jpg)